BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 25, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Aug. 4, 2025

Aug. 4, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Allogene, Enegenesis, Spine.
Read More

In the clinic for August 1, 2025

Aug. 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sequana Medical.
Read More

In the clinic for Aug. 1, 2025

Aug. 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Eli Lilly, Gri, Instil, Nuvectis, Soligenix.
Read More

In the clinic for July 31, 2025

July 31, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioaffinity Technologies, Etiometry, Evvy, Guardant Health, Omron Healthcare, Preludedx.
Read More

In the clinic for July 31, 2025

July 31, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aclaris, Aerorx, Biogen, Cardiff, Eisai, Eli Lilly, Kane, Newamsterdam, Tenaya, Vyne.
Read More

In the clinic for July 30, 2025

July 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anika Therapeutics, Conavi Medical, Inbrain Neuroelectronics, Neuronetics.
Read More

In the clinic for July 30, 2025

July 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Aim, Alfasigma, Alterity, Alzcure, Celcuity, Cervomed, Cognition, Eli Lilly, Fulcrum. Nkgen, Recognify, Servier, Taran, Urogen.
Read More

In the clinic for July 29, 2025

July 29, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Maui Imaging, Nyxoah, Qynapse, Veravas.
Read More

In the clinic for July 29, 2025

July 29, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adocia, Kintor.
Read More

In the clinic for July 28, 2025

July 28, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hyperfine.
Read More
Previous 1 2 … 35 36 37 38 39 40 41 42 43 … 329 330 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 21, 2026
  • Tree in the shape of human head losing leaves

    KBN-2201 reverses key features of Alzheimer’s in mice

    BioWorld Science
    Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld Science
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing